4/A: Coeptis Therapeutics Holdings Executive Buys Shares
Insider Transaction (Form 4/A)
Christopher Ryan Schadel, Chief Marketing Officer of Coeptis Therapeutics Holdings, Inc., purchased 1,000 shares of common stock on July 27, 2026 for $3.92 per share.
Summary
- Option exercise/conversion: acquired 2,467 Common Stock on July 27, 2026; holds 2,467 after (Direct).
- Open-market purchase: acquired 1,000 Common Stock at $3.92 ($3,920) on August 18, 2026; holds 3,467 after (Direct).
- Option exercise/conversion: acquired 702 Common Stock on September 3, 2026; holds 4,169 after (Direct).
- Option exercise/conversion: disposed of 2,467 Restricted Stock Units on July 27, 2026; holds 10,207 after (Direct).
- Option exercise/conversion: disposed of 702 Restricted Stock Units on September 3, 2026; holds 9,505 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $3,920, committing personal capital to the stock.
Insider Transactions
Christopher Ryan Schadel — Officer (Chief Marketing Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-27 | Option exercise/conversion | Common Stock | 2,467 | — | — | 2,467 |
| 2026-08-18 | Open-market purchase | Common Stock | 1,000 | $4 | $3.9K | 3,467 |
| 2026-09-03 | Option exercise/conversion | Common Stock | 702 | — | — | 4,169 |
| 2026-07-27 | Option exercise/conversion | Restricted Stock Units | 2,467 | — | — | 10,207 |
| 2026-09-03 | Option exercise/conversion | Restricted Stock Units | 702 | — | — | 9,505 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-27 | Option exercise/conversion (2,467 shares) |
| 2026-08-18 | Open-market purchase (1,000 shares) |
| 2026-09-03 | Option exercise/conversion (702 shares) |
| 2026-07-27 | Option exercise/conversion (2,467 shares) |
| 2026-09-03 | Option exercise/conversion (702 shares) |
Keywords
insider transaction, Form 4/A, ZSQR, Z Squared Inc., bullish, Christopher Ryan Schadel
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.